C
VERA icon

Covestor’s Vera Therapeutics VERA Stock Holding History

Covestor’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
4
– – ﹤0.01% 2808
2025
Q4 		$0 Hold
4
– – ﹤0.01% 2773
2025
Q3 		$0 Hold
4
– – ﹤0.01% 2812
2025
Q2 		$0 Hold
4
– – ﹤0.01% 2792
2025
Q1 		$0 Buy
4
+1
+33% +$32 ﹤0.01% 2764
2024
Q4 		$0 Buy
3
+1
+50% +$44 ﹤0.01% 2777
2024
Q3 		$0 Sell
2
-1
-33% -$38 ﹤0.01% 2812
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2796
2024
Q1 		$0 Buy
+3
New +$107 ﹤0.01% 2785

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Covestor's VERA Position: Q1 2026 in Review

Covestor held its Vera Therapeutics (VERA) position steady in Q1 2026 at 4 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2808.

Covestor first reported a position in VERA in Q1 2024 and has held it in 9 quarters since. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Covestor held 4 shares of Vera Therapeutics worth $0 as of Q1 2026.
  • Covestor left its Vera Therapeutics share count unchanged in Q1 2026.
  • Vera Therapeutics made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2808 holding.
  • Covestor first reported a position in Vera Therapeutics in Q1 2024 and has held it in 9 quarters since.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.